Eqis Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Eqis Capital Management, Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Eqis Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 11,766 shares of BMY stock, worth $679,604. This represents 0.05% of its overall portfolio holdings.
Number of Shares
11,766
Previous 35,692
67.03%
Holding current value
$679,604
Previous $1.48 Million
58.97%
% of portfolio
0.05%
Previous 0.13%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.37 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...